Related Experiment Video
Updated: May 20, 2026
06:48
Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment
Published on: June 25, 2019
Alzheimer's disease and semantic deficits: a feature-listing study
Roberta Perri1, Giandaniele Zannino, Carlo Caltagirone
1Laboratory of Clinical and Behavioural Neurology, IRCCS Santa Lucia Foundation, Rome, Italy. r.perri@hsantalucia.it
Neuropsychology
|July 18, 2012
Summary
Alzheimer's disease (AD) impairs semantic knowledge, with superordinate and nonsensory features being more preserved. Early acquired concepts and feature dominance influence resilience to cognitive decline in AD patients.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Gerontology
Background:
- Alzheimer's disease (AD) leads to progressive cognitive decline, significantly impacting semantic memory.
- Understanding the specific patterns of semantic impairment is crucial for early diagnosis and intervention.
Purpose of the Study:
- To investigate the qualitative characteristics of semantic impairment in mild to moderate Alzheimer's disease (AD).
- To determine if subordinate/distinctive features are affected earlier than superordinate/shared features.
- To assess the vulnerability of sensory versus nonsensory features and the influence of feature dominance and acquisition age on semantic resilience.
Main Methods:
- A feature-listing task was administered to patients with mild/moderate AD and healthy controls.
- Concepts were selected from a normative database to quantify semantic indexes like feature type, distinctiveness, correlation, and dominance.
Main Results:
- Semantic knowledge is generally reduced in AD patients.
- Superordinate knowledge and nonsensory information are better preserved than other types.
- Highly shared features are less affected than distinctive ones; feature dominance and age of acquisition influence production.
Conclusions:
- Feature type and distinctiveness are highly sensitive to AD's effects on semantic representations.
- AD patients retain implicit knowledge of feature informativeness.
- Early concept acquisition enhances resilience to semantic degradation in AD.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
08:17A Semantic Priming Event-related Potential (ERP) Task to Study Lexico-semantic and Visuo-semantic Processing in Autism Spectrum Disorder
Published on: April 12, 2018
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...